← FDA DRUG APPROVALS

FDA NDA · NDA010796

HARMONYL

Sponsor: ABBVIE

APPLICATION
NDA010796
TYPE
NDA
ORIGINAL APPROVAL
1957-04-19
LATEST ACTION
2009-03-13
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

HARMONYLDiscontinued
DESERPIDINE 0.25MG · TABLET · ORAL
HARMONYLDiscontinued
DESERPIDINE 0.1MG · TABLET · ORAL

Approval history

2009-03-13Labeling · Supplement 7AP
1991-09-25Labeling · Supplement 11AP
1984-03-05Labeling · Supplement 13AP
1983-12-15Manufacturing (CMC) · Supplement 12 · standardAP
1982-07-16Manufacturing (CMC) · Supplement 10 · standardAP
1982-07-16Manufacturing (CMC) · Supplement 9 · standardAP
1980-01-28Labeling · Supplement 8AP
1957-04-19Type 1 - New Molecular Entity · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →